Observed and projected prevalence of prurigo nodularis in a commercially and Medicare-insured US population

被引：0
|
作者：
Gabriel, Sylvie [1 ]
Kwatra, Shawn G. [2 ]
Puelles, Jorge [3 ]
机构：
[1] Galderma, Lausanne, Switzerland
[2] Johns Hopkins Univ Sch Med, Baltimore, MD USA
[3] Galderma SA, La Tour De Peilz, Vaud, Switzerland
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
34095
引用
收藏
页码：AB86 / AB86
页数：1
相关论文
共 50 条
  • [31] Medical resource utilization in nonhemorrhagic stroke in a commercially insured US population
    McCollam, PL
    Ollendorf, DA
    Dennett, S
    STROKE, 2006, 37 (02) : 742 - 742
  • [32] Prevalence and risk factors for high-frequency basal cell carcinoma in a large commercially insured population in the US
    Chiang, A.
    Solis, D.
    Kim, G. E.
    Cho, H.
    Lapidus, D.
    Li, S.
    Sarin, K. Y.
    Tang, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S57 - S57
  • [33] Risk factors for developing epilepsy in a US commercially insured pediatric population
    Oh, Ahyuda
    Thurman, David
    Kim, Hyunmi
    NEUROLOGY, 2017, 88
  • [34] Incidence and Costs of Cervical Intraepithelial Neoplasia in a US Commercially Insured Population
    Henk, Henry J.
    Insinga, Ralph P.
    Singhal, Puneet K.
    Darkow, Theodore
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2010, 14 (01) : 29 - 36
  • [35] ESTIMATES OF POSTPARTUM DEPRESSION PREVALENCE IN A COMMERCIALLY INSURED POPULATION - A RETROSPECTIVE ANALYSIS
    Bonthapally, V
    Broder, M. S.
    Tieu, R. S.
    Gannu, L.
    Meltzer-Brody, S.
    Chang, E.
    VALUE IN HEALTH, 2017, 20 (05) : A350 - A350
  • [36] Patient Perspectives on the Burden of Heart Failure with Preserved Ejection Fraction in a US Commercially Insured and Medicare Advantage Population: A Survey Study
    Nguyen, Chi
    Bamber, Luke
    Willey, Vincent J.
    Evers, Thomas
    Power, Thomas P.
    Stephenson, Judith J.
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 1181 - 1196
  • [37] Real-World Effectiveness of Semaglutide in Early Users from a US Commercially Insured (CI) and Medicare Advantage (MA) Population
    Visaria, Jay
    Dang-Tan, Tam
    Petraro, Paul V.
    Nepal, Bal K.
    Willey, Vincent
    DIABETES, 2019, 68
  • [38] Prevalence of conditions in the US employer-insured population
    Hansen, L. G.
    Chang, S.
    Foley, K.
    VALUE IN HEALTH, 2008, 11 (03) : A45 - A45
  • [39] Trends of Immune Globulin Utilization in US Commercially Insured and Medicare Populations, 2009-2019
    Jiao, Yixin
    Moll, Keran
    Dores, Graca M.
    Tworkoski, Ellen
    Zhou, Cindy Ke
    Scott, Dorothy E.
    Wong, Hui-Lee
    Fingar, Kathryn
    Burrell, Timothy
    McEvoy, Rowan
    Hobbi, Shayan
    Chillarige, Yoganand
    Obidi, Joyce
    MaCurdy, Thomas E.
    Kelman, Jeffrey A.
    Shoaibi, Azadeh
    TRANSFUSION, 2022, 62 : 204A - 205A
  • [40] Impact of Rifaximin Use on Overt Hepatic Encephalopathy (OHE) Rehospitalizations Post-Discharge From an OHE Hospitalization in Commercially and Medicare-Insured Patients
    Jesudian, Arun B.
    Gagnon-Sanschagrin, Patrick
    Bungay, Rebecca
    Easson, Kaitlyn
    Shah, Aditi
    Guerin, Annie
    Samson, Aaron
    Olujohungbe, Olamide
    Bumpass, Brock
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1240 - S1241
12345